Zheng Mei, An Seungchan, Park In Guk, Kim Jino, Kim Won-Serk, Noh Minsoo, Sung Jong-Hyuk
Epi Biotech Co., Ltd., Incheon 21983, Republic of Korea.
College of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
Int J Mol Sci. 2024 Dec 26;26(1):95. doi: 10.3390/ijms26010095.
We previously demonstrated that C-X-C Motif Chemokine Ligand 12 (CXCL12) is primarily secreted by dermal fibroblasts in response to androgens and induces hair miniaturization in the mouse androgenic alopecia (AGA) model. However, the direct effects of androgen-induced CXCL12 on dermal papilla cells (DPCs) and dermal sheath cup cells (DSCs) have not been demonstrated. First, we compared single-cell RNA sequencing data between mouse and human skin, and the results show that CXCL12 is highly co-expressed with the androgen receptor (AR) in the DPCs and DSCs of only human hair. Immunohistochemistry also showed that CXCL12 is co-expressed with the AR in the DPCs and DSCs of human hair follicles. In human hair organ culture, androgens also increased CXCL12 expression in DPCs and DSCs and reduced hair length, while the CXCL12 antibody increased hair length via AR inactivation. CXCL12 mRNA was upregulated by androgen treatment in primary human DPCs and DSCs. On the contrary, AR inhibitors or siRNA treatment reduced CXCL12 expression. Collectively, these results suggest that CXCL12 is co-expressed with the AR in the DPCs and DSCs of human hair follicles; therefore, inhibition of CXCL12 using antibodies is a promising strategy for AGA treatment.
我们之前证明,C-X-C基序趋化因子配体12(CXCL12)主要由真皮成纤维细胞在雄激素作用下分泌,并在小鼠雄激素性脱发(AGA)模型中诱导毛发小型化。然而,雄激素诱导的CXCL12对毛乳头细胞(DPCs)和毛鞘杯状细胞(DSCs)的直接作用尚未得到证实。首先,我们比较了小鼠和人类皮肤之间的单细胞RNA测序数据,结果表明,CXCL12仅在人类毛发的DPCs和DSCs中与雄激素受体(AR)高度共表达。免疫组织化学也显示,CXCL12在人类毛囊的DPCs和DSCs中与AR共表达。在人类毛发器官培养中,雄激素也增加了DPCs和DSCs中CXCL12的表达并缩短了毛发长度,而CXCL12抗体通过AR失活增加了毛发长度。在原代人DPCs和DSCs中,雄激素处理上调了CXCL12 mRNA。相反,AR抑制剂或siRNA处理降低了CXCL12的表达。总体而言,这些结果表明,CXCL12在人类毛囊的DPCs和DSCs中与AR共表达;因此,使用抗体抑制CXCL12是一种有前景的AGA治疗策略。